Kolexia
Bronowicki Jean Pierre
Gastro-entérologie
Hôpital Brabois
Vandoeuvre-lès-Nancy, France
306 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Hépatite Carcinome hépatocellulaire Hépatite C Hépatite C chronique Carcinomes Tumeurs du foie Cirrhose du foie Fibrose Hépatite chronique

Industries

Gilead
29 collaboration(s)
Dernière en 2023
Roche
28 collaboration(s)
Dernière en 2023
Bayer
19 collaboration(s)
Dernière en 2023
Abbvie
17 collaboration(s)
Dernière en 2023

Dernières activités

Prevalence of hepatitis C, hepatitis B and HIV and their therapeutic management in a French public psychiatric hospital.
L'Encephale   16 février 2024
Validation of the New Vibration-guided FibroScan Examination
Essai Clinique (Echosens)   16 février 2024
NATiV3: A Randomised, Double-blind, Placebo-controlled, Multicentre, Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With Non-cirrhotic Non-alcoholic Steatohepatitis (NASH) and Fibrosis Stages F2 and F3
Essai Clinique (Inventiva Pharma)   24 janvier 2024
SCREANIT: SCREaning of Advanced Liver Fibrosis Using Non-Invasive Tests in General Population
Essai Clinique (CHU Angers)   08 janvier 2024
Serum infrared spectral profile is predictive of the degree of hepatic fibrosis in chronic hepatitis C patients.
Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy   25 septembre 2023
Unresectable hepatocellular carcinoma at dawn of immunotherapy era: real-world data from the French prospective CHIEF cohort.
European journal of gastroenterology & hepatology   11 août 2023
Atezolizumab plus bevacizumab in advanced hepatocellular carcinoma after treatment failure with multikinase inhibitors.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver   03 avril 2023
COVID19-CHIEF: Impact of COVID-19 Infection in Patients With Hepatocellular Carcinoma: An Ambispective Study Nestled in the CHIEF Cohort
Essai Clinique (CHU Amiens-Picardie)   21 mars 2023
BEZURSO: Multicenter, Randomized, Double-blind Placebo Controlled Trial of Bezafibrate for the Treatment of Primary Biliary Cirrhosis in Patients With Incomplete Response to Ursodesoxycholic Acid Therapy.
Essai Clinique (Assistance publique – Hôpitaux de Paris)   23 février 2023
Impact of adjuvant sorafenib treatment after local ablation for HCC in the phase II SORAMIC trial.
JHEP reports : innovation in hepatology   15 février 2023